Susan Faye Dent, MD
I am a medical oncologist and professor of medicine at Duke University. I am the associate director of breast cancer clinical research and co-director of the cardio-oncology Program at Duke University. My interest in the toxicities of cancer treatments, in particular, cardiotoxicity, led to the 2008 establishment of the first cardio-oncology clinic in Ottawa, Canada. I subsequently established the not-for-profit Canadian Cardiac Oncology Network (CCON) in 2011, an organization dedicated to learning how to deliver optimal cancer therapy without compromising cardiovascular health. In 2015, I launched the Global Cardio-Oncology Summit (GCOS), an annual meeting designed to bring health care providers from around the world together to learn about the potential cardiovascular impact of cancer therapies. As a faculty member at Duke University, I plan to use my expertise to promote breast cancer clinical research in order to provide the best care for cancer patients and foster the growth and development of a cardio-oncology program.
Ratings and Reviews
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Training and Education
Clinical Focus and Research
My research over the last 20 years has focused on novel and emerging therapies for breast cancer as well as treatment-related toxicities including cardiotoxicity. I have led, as the principal investigator for Canada, a global phase III breast cancer trial, and I have been actively involved in steering committees at the International level. I have been a co-investigator of a number of investigator-initiated peer-reviewed funded studies and have been an active member of grant review boards including the Canadian Institute for Health Research (CIHR) and the Canadian Breast Cancer Foundation (CBCF). At the national level, I served for several years as a member of the clinical guidance panel for breast cancer for the Pan Canadian Drug Review. At Duke Health, my research will focus on identifying patients who are at risk of experiencing cancer therapy-related to cardiac dysfunction as well as optimizing cardiac health in order to provide optimal cancer therapy.
Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below.
- Aetna Choice POS, Aetna Choice POS II
- Aetna Elect Choice HMO, Aetna Open Access Elect Choice
- Aetna Health Network Only, Aetna Health Network Option
- Aetna HMO
- Aetna Limited Benefit Insurance PPO
- Aetna Managed Choice POS
- Aetna Medicare Value Plan (HMO)
- Aetna Medicare Value Plus Plan (HMO)
- Aetna Medicare Essential Plan (PPO)
- Aetna Medicare Eagle Plan (PPO)
- Aetna Open Access HMO, Open Access Aetna Select, Aetna Open Access Managed Choice
- Aetna Open Choice PPO
- Aetna PCP Coordinated POS Plan
- Aetna Quality Point of Service (QPOS)
- Aetna Select HMO
- Aetna Traditional Choice
- Aetna Voluntary Indemnity Group Plan
- Aetna Whole Health – Duke WakeMed WKCC
- Ambetter of North Carolina
Blue Cross Blue Shield of NC
- Blue Advantage
- Blue Medicare (HMO, PPO)*
- Blue Options (123, PPO, HSA)
- Blue Select
- NC State Employees Health Plan
*Duke HomeCare and Hospice does not participate in the plan.
- Bright Health
- Cigna Behavioral Health (*Limited eligibility)
- Cigna Choice Plus
- Cigna Connect Individual Family Plan
- Cigna Open Access
- Cigna Open Access Plus
*Please call Cigna Behavioral Heath to see if the provider is participating in your plan.
Duke Group Plans
- Duke Basic
- Duke Select
- Experience Health Medicare Advantage (HMO) Plan
- First Health
- Gateway Health Alliance
- Halifax Physician-Hospital Organization
- Humana Choice (PPO)
- Humana Choice - Medicare Advantage (PPO)
- Humana ChoiceCare - Medicare Advantage (PPO)
- Humana Gold Choice - Medicare Advantage (PFFS)
- Humana Gold Plus - Medicare Advantage (HMO)
- Humana Medicare Advantage Group Plan - NC State Retirees
- First Medicare Direct*
- Medicare Part A
- Medicare Part B
*This is for Wake County only.
- MultiPlan / Private Healthcare Systems
- NC Medicaid*
*Not all Duke locations and doctors participate in this plan. Please contact the location you will be visiting to determine what is accepted.
- OneNet PPO
- Optima Family Care (Medicaid HMO in VA)*
- Optima Individual & Family (On & Off Exchange Plans)
- Optima Plus (PPO)
- Optima Vantage (HMO)
*Duke Primary Care, Duke University Hospital, Duke Regional Hospital, and Duke Raleigh Hospital are not participating with this plan.
- TRICARE Prime
- TRICARE Prime Remote
- TRICARE Select
- AARP Medicare Complete (HMO, PPO)*
- AARP Medicare Complete Essential (HMO)*
- All Savers Alternate Funding
- All Savers Fully Insured
- United Healthcare (HMO, PPO, POS)
- United Healthcare Charter/Charter Balance/Charter Plus
- United Healthcare Choice/Choice Plus
- United Healthcare Core/Core Essential
- United Healthcare Navigate/Navigate Plus/Navigate Balanced
- United Healthcare of the River Valley
- United Healthcare Option PPO
- United Healthcare Options PPO with Harvard Pilgrim
- United Healthcare Passport Connect Choice/Choice Plus
- United Healthcare Passport Connect Options PPO
- United Healthcare Select/Select Plus
- United Medical Resources (UMR)
*Duke HomeCare and Hospice, freestanding radiology locations, and mental health providers do not participate with the plan.
Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
- Novartis pharmaceuticals